Key points are not available for this paper at this time.
Senescent RPE cells can accelerate pathological neovascularization; thus, senescent cell-targeting therapy has great clinical potential for wAMD.
Share your take
Add a clinician perspective alongside expert commentary.
Wang et al. (Tue,) studied this question.